Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2017/0360766 3-(PIPERIDIN-4-YL)-ISOXAZOL-3(OH)-ONES FOR TREATMENT OF DERMATOLOGIC DISORDERS
Described are a group of isoxazol-3(2H)-one analogues and their use in topical formulations for the treatment and prophylaxis of dermatological disorders.
2017/0360765 SUBSTITUTED PYRIDINES AS BROMODOMAiN INHIBITORS
The disclosure relates to substituted pyridines, which are useful for inhibition of BET protein function by binding to bromodomains, and their use in therapy.
2017/0360764 USE OF EP4 RECEPTOR ANTAGONISTS IN THE TREATMENT OF CARTILAGE DISEASE
This invention relates to a compound with EP4 antagonistic activity, or a pharmaceutically acceptable salt with EP4 receptor antagonistic activities, which is...
2017/0360763 METHODS OF USE OF CYCLOPAMINE ANALOGS
The invention provides methods for treating various conditions using derivatives of cyclopamine having the following formula: ##STR00001##
2017/0360762 COMBINATION OF IBUDILAST AND RILUZOLE AND METHODS OF USING SAME
The present disclosure relates generally to methods for treating neurodegenerative diseases, including their progressive forms. In particular, the present...
2017/0360761 Selective Inhibition of HDAC6 and HDAC8, and Methods of Use Thereof
The present invention relates to methods of selectively modulating (for example inhibiting) the activity of histone deacetylase 6 and/or 8 (HDAC6 and/or...
2017/0360760 Inhibitors of Bromodomains
The present disclosure relates to compounds capable of acting as covalent inhibitors of bromodomains and the therapeutic use of these inhibitors.
2017/0360759 CARBAMOYLOXYMETHYL TRIAZOLE CYCLOHEXYL ACIDS AS LPA ANTAGONISTS
The present invention provides compounds of Formula (I): ##STR00001## or stereoisomers, tautomers, pharmaceutically acceptable salts, solvates or prodrugs...
2017/0360758 COMPOSITION FOR EXTERMINATING SCUTICOCILIATES IN FISH INCLUDING MEBENDAZOLE
The present disclosure relates to a composition for exterminating scuticociliates in fish, comprising Mebendazole as an active ingredient, and to a method for...
2017/0360757 BENZIMIDAZOLE DERIVATIVES: PREPARATION AND PHARMACEUTICAL APPLICATIONS
The present invention relates to hydroxamate compounds which are inhibitors of histone deacetylase. More particularly, the present invention relates to...
2017/0360756 SUBSTITUTED HETEROCYCLES AS BROMODOMAIN INHIBITORS
The present application relates to substituted heterocycles compound of Formula I and pharmaceutical compositions thereof useful for the inhibition of BET...
2017/0360755 COMPOSITIONS AND METHODS OF MODULATING S-NITROSYLATION
A method of treating disorders associated with NO/SNO deficiency or benefiting from increased SNO in a subject in need thereof includes administering to the...
2017/0360754 ANTICANCER COMPOSITIONS
The present invention concerns pharmaceutical formulations of ARN-509, which can be administered to a mammal, in particular a human, suffering from an androgen...
2017/0360753 ORGANIC COMPOUNDS
The present invention relates to certain PDE2 inhibitory compounds, in free or salt form, pharmaceutical compositions containing such compounds and methods for...
2017/0360752 ANTIVIRAL AGENTS DIRECTED AGAINST RESPIRATORY SYNCYTIAL VIRUS
The present invention relates to N1-benzyl substituted pyrazoles as antiviral agents directed against respiratory syncytial virus.
2017/0360751 Methods and Compositions for the Treatment of Retinopathy and Other Ocular Diseases
Compositions and methods for the treatment of ocular diseases are disclosed.
2017/0360750 SUNITINIB FORMULATIONS AND METHODS FOR USE THEREOF IN TREATMENT OF GLAUCOMA
Methods for increasing the encapsulation or incorporation of Sunitinib into polymeric matrices have been developed. The resulting formulations provide for more...
2017/0360749 METHOD OF PREVENTING OR TREATING A PULMONARY DISEASE OR CONDITION
A pharmaceutical composition for aerosol administration and method of preventing or treating a pulmonary disease or condition in a subject with a SphK1...
2017/0360748 SELECTIVE HDAC6 INHIBITORS AND USES THEREOF
The present invention relates to selective Histone deacetylase 6 (HDAC6) inhibitors and compositions containing the same. Methods of treating diseases and...
2017/0360747 USE OF ZILEUTON FOR THE TREATMENT OF NASAL POLYPS IN CYSTIC FIBROSIS PATIENTS
The present invention provides methods of treating nasal polyps in cystic fibrosis patients using zileuton. The present invention also provides methods of...
2017/0360746 POLYMORPH OF GRANATICIN B
The present invention provides a crystalline Form A of Compound 1, also referred to as Granaticin B, and pharmaceutically compositions thereof. The present...
2017/0360745 CANNABIS EXTRACTS AND METHODS OF PREPARING AND USING SAME
The invention relates to the extraction of pharmaceutically active components from plant materials, and more particularly to the preparation of a botanical...
2017/0360744 AGENT CONTAINING FLAVONOID DERIVATIVES FOR TREATING CANCER AND INFLAMMATION
A pharmaceutical composition for the prevention and treatment of cancer with specific flavanoid-based compounds selected from among the groups of Flavone,...
2017/0360743 BIFLAVONE COMPOUND AND USES THEREOF FOR TREATING CANCERS AND PREPARING DRUGS
Provided in the present invention is a compound having these structure of formula I or a pharmaceutically acceptable salt thereof. Also provided in the present...
2017/0360742 Formulations For Cathepsin K Inhibitors
The instant invention relates to pharmaceutical compositions containing cathespin K inhibitors. Also disclosed are processes for making said pharmaceutical...
2017/0360741 Pharmaceutical Formulation for Histone Deacetylase Inhibitors
A pharmaceutical composition, comprising a therapeutically effective amount of an active pharmaceutical ingredient (API) compound represented by the following...
2017/0360740 HISTONE DEACETYLASE INHIBITORS
In recognition of the need to develop novel therapeutic agents, the present invention provides novel histone deacetylase inhibitors. These compounds include an...
2017/0360739 COMPOSITIONS AND METHODS COMPRISING MEDIUM CHAIN TRIGLYCERIDES FOR TREATMENT OF EPILEPSY
The invention provides compositions and methods for treatment of epilepsy in an animal. In one embodiment, a method for treating epilepsy in a companion animal...
2017/0360738 COMPOSITIONS CONTAINING AS THE ACTIVE INGREDIENT COMPONENTS FROM SALVIA SCLAREA SEED
The present invention concerns a food supplement comprising Salvia sclarea seeds, or flour, oil or pulp or extracts obtained from the seeds as well as finished...
2017/0360737 LONG-CHAIN POLYUNSATURATED FATTY-ACID-CONTAINING FAT AND FOOD CONTAINING SAME
The present invention addresses the problem of providing a versatile, flavorful long-chain polyunsaturated fatty-acid-containing fat having exceptional...
2017/0360736 Compositions And Methods For Treating Intestinal Hyperpermeability
The present invention provides methods, compositions, and kits for treating intestinal hyperpermeability in a subject in need thereof, including conditions...
2017/0360735 INGESTIBLE EMULSION MATRIX FOR DELIVERY OF CREATINE
Disclosed are compositions for improved oral delivery of creatine, methods of making such compositions, and kits comprising such compositions. In particular,...
2017/0360734 ANTI-RDS COMPOUNDS AND METHOD OF MANUFACTURE AND ADMINISTRATION THEREOF TO INDUCE DOPAMINE HOMEOSTATIS
Compounds for treating reward deficiency syndrome (RDS) behaviors and methods of use and administration of such compounds to induce dopamine homeostasis. These...
2017/0360733 AGING INHIBITOR
An object of the present invention is to provide a senescence retarding agent that delays the onset of senescence symptoms and extends longevity, and is...
2017/0360732 Methods and Drug Therapies for Patency of Occluded Blood Vessels Following Angioplasty
The present disclosure relates to a method of maintaining luminal patency of a blood vessel following vessel injury, the method including administering a...
2017/0360731 IMMUNOMODULATOR
An immunomodulator useful for modulating immune function and maintaining intravital homeostasis is provided. The immunomodulator comprises S-1-propenycysteine...
2017/0360730 MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
The present invention relates to amide derivatives of Formula (XIIIa) and pharmaceutical compositions thereof that modulate the activity of the PGI2 receptor....
2017/0360729 TOPICAL DAPSONE AND DAPSONE/ADAPALENE COMPOSITIONS AND METHODS FOR USE THEREOF
Dapsone and dapsone/adapalene compositions can be useful for treating a variety of dermatological conditions. The compositions of this disclosure include...
2017/0360728 SYSTEMS AND METHODS FOR BIO-MATCHING GELS, CREAMS AND LOTIONS
A method of bio-matching a topical gel, cream or lotion includes selecting a vagina of a living body, identifying a secretion of the selected vagina,...
2017/0360727 PHARMACEUTICAL COMPOSITION FOR TREATING CANCER, CONTAINING LACTATE METAL SALT
The present invention relates to: a pharmaceutical composition for treating cancer containing, as an active ingredient, a metal lactate salt, which can be...
2017/0360726 COMPOUNDS, COMPOSITIONS AND METHODS OF USE
Herein, compounds, compositions and methods for modulating inclusion formation and stress granules in cells related to the onset of neurodegenerative diseases,...
2017/0360725 FKBP52-SPECIFIC ANDROGEN RECEPTOR INHIBITOR, MJC13, FOR USE IN TREATING BREAST CANCER
Embodiments of the current invention include methods and compositions for treating breast cancer by administering an effective amount of MJC13 to a subject in...
2017/0360724 METHODS OF PREVENTING NEURODEGENERATION OF ASSOCIATION CORTEX IN A MAMMAL
The present invention provides methods of preventing and/or reducing risk of neurodegeneration of association cortex, and/or inhibiting or reversing formation...
2017/0360723 USE OF RASAGILINE FOR THE TREATMENT OF RESTLESS LEGS SYNDROME
Disclosed are methods for the treatment of Restless Legs Syndrome comprising administering an amount of R(+)-N-propargyl-1-aminoindan or a pharmaceutically...
2017/0360722 2-DODECYL-6-METHOXYCYCLOHEXA-2,5-DIENE-1,4-DIONE AS A CANCER THERAPEUTIC
2-Dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione (DMDD), as well as variants, derivatives, analogs, modifications, and conjugates thereof, are identified as...
2017/0360720 METHOD TO SUPPLEMENT HUMAN IMMUNE SYSTEM IN SUPPRESSING HSV SYMPTOMS
Some embodiments of the invention relate to methods of administering orally a therapeutically effective pharmaceutical formulation of between about 3,000...
2017/0360719 NOVEL METHOD OF USE
The present invention relates to a novel method of treatment of acne in a human patient in need thereof, comprising administering topically to said patient an...
2017/0360718 INTRANASAL DENTAL ANESTHETIC
The present invention relates to intranasally administered pharmaceutical compositions administered for use in anesthesia. Such pharmaceutical compositions...
2017/0360717 Nanowire-Coated Microdevice and Method of Making and Using the Same
A microdevice containing a plurality of nanowires on a biocompatible surface, and methods of making and using the same are provided. Aspects of the present...
2017/0360716 SEPARABLE CAPSULE
The present disclosure relates to a separable hard capsule for containing a medication. The capsule may be opened by finger force and used, for example, by...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.